The feather epithelium contributes to the dissemination and ecology of clade 2.3.4.4b H5 high pathogenicity avian influenza viruses in ducks

Emerg Microbes Infect. 2023 Dec;12(2):2272644. doi: 10.1080/22221751.2023.2272644. Epub 2023 Nov 3.

Abstract

Immature feathers are known replication sites for high pathogenicity avian influenza viruses (HPAIVs) in poultry. However, it is unclear whether feathers play an active role in viral transmission. This study aims to investigate the contribution of the feather epithelium to the dissemination of clade 2.3.4.4b goose/Guangdong/1996 lineage H5 HPAIVs in the environment, based on natural and experimental infections of domestic mule and Muscovy ducks. During the 2016-2022 outbreaks, H5 HPAIVs exhibited persistent and marked feather epitheliotropism in naturally infected commercial ducks. Infection of the feather epithelium resulted in epithelial necrosis and disruption, as well as the production and environmental shedding of infectious virions. Viral and feather antigens colocalized in dust samples obtained from poultry barns housing naturally infected birds. In summary, the feather epithelium contributes to viral replication, and it is a likely source of environmental infectious material. This underestimated excretion route could greatly impact the ecology of HPAIVs, facilitating airborne and preening-related infections within a flock, and promoting prolonged viral infectivity and long-distance viral transmission between poultry farms.

Keywords: Avian influenza; aerosol; environment; feather; viral tropism.

MeSH terms

  • Animals
  • Ducks
  • Epithelium
  • Feathers
  • Influenza A virus*
  • Influenza in Birds*
  • Poultry
  • Poultry Diseases*
  • Virulence

Grants and funding

This study was performed in the framework of the “Chaire de Biosécurité et Santé Aviaires”, hosted by the National Veterinary College of Toulouse (ENVT) and funded by the Direction Generale de l’Alimentation, Ministère de l’Agriculture et de la Souveraineté Alimentaire, France. The animal experiment was partially funded by the Veterinary Biocontained facility Network (VetBioNet) [EU Grant Agreement INFRA-2016-1 N°731014].